{
    "nctId": "NCT02590653",
    "officialTitle": "Assessment of the Effects of Aggressive Atorvastatin Therapy on Myocardial Deformation Characteristics, Vascular Rigidity, 24 Hour ECG Monitoring Parameters and Quality of Life in Patients With STEMI",
    "inclusionCriteria": "1. Signed Informed Consent Form\n2. Patients having physical and mental ability to participate in the study\n3. Patients of both sexes aged 35 to 65 years\n4. Presence of documented ST-elevation myocardial infarction confirmed by ECG, as well as troponin I and CK-MB levels.\n5. Presence of hemodynamically relevant stenosis of one artery (i.e., the infarct-related artery) confirmed by coronary angiography (CAG), with the occlusion of other arteries not exceeding 30%.\n* Must have minimum age of 35 Years\n* Must have maximum age of 65 Years",
    "exclusionCriteria": "1. A history of repeat or recurrent myocardial infarction;\n2. A history of chronic heart failure (CHF) III-IV by New-York Heart Association (NYHA);\n3. Presence of left ventricular hypertrophy confirmed by echocardiography;\n4. QRS complex exceeding 1.0;\n5. Ejection fraction less than 40%;\n6. Presence of hemodynamically relevant stenosis exceeding 30% in several coronary arteries confirmed by CAG;\n7. Type 1 diabetes mellitus;\n8. Type 2 diabetes mellitus requiring pharmacotherapeutic correction with insulin;\n9. Any severe concurrent disease;\n10. A history of acute cerebrovascular accident (ACVA) within the 6 month period preceding the study;\n11. Active hepatic disease or liver enzyme elevation of unclear etiology more than 3 times higher than the upper limit of normal;\n12. Hepatic failure or bilirubin elevation more than 1.5 times higher than the upper limit of normal;\n13. Uncontrolled arterial hypertension (AH), with systolic blood pressure (SBP) exceeding 180 mm Hg and diastolic blood pressure (DBP) exceeding 110 mm Hg;\n14. A history of heart rhythm and/or cardiac conduction disorder;\n15. Inborn and/or acquired heart defects;\n16. A history of aortic aneurysm;\n17. Current existence of severe anemia (Hb \\< 100 g/L);\n18. Chronic renal disease (creatinine clearance \\< 30 mL/min);\n19. Uncorrected thyroid dysfunction, with hyper- or hypothyroidism;\n20. Intolerance of statins;\n21. Alcohol abuse and drug use;\n22. Participation in other clinical studies within the last two months."
}